Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daniel Neureiter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
Jung, T. (First author), Neureiter, D. (Co-author), Schweighofer-Zwink, G. (Co-author), Rendl, G. (Co-author), Pirich, C. (Co-author) & Beheshti, M. (Last author), 6 Jan 2025, In: EJNMMI reports. 9, 1, p. 2 3 p., 2.Research output: Contribution to journal › Short comment / notes › peer-review
Open Access -
Does Total Neoadjuvant Therapy Impact Surgical Precision in Total Mesorectal Excision? A Nationwide Survey of the Experiences of Expert Surgeons
Jäger, T. (First author), Zitt, M., Riss, S., Presl, J. (Co-author), Schredl, P. (Co-author), Neureiter, D. (Co-author), Ramspott, J. P., Tschann, P., Brunner, W., ACO-ASSO CRC study group, Königsrainer, I., Emmanuel, K. (Co-author) & Aigner, F., 17 Jan 2025, In: Cancers. 17, 2, 18 p., 283.Research output: Contribution to journal › Original Article › peer-review
Open Access -
The importance of preclinical models for cholangiocarcinoma drug discovery
Krendl, F. J., Primavesi, F. (Co-author), Oberhuber, R., Neureiter, D. (Co-author), Ocker, M., Bekric, D. (Co-author), Kiesslich, T. (Co-author) & Mayr, C. (Last author), 7 Feb 2025, In: EXPERT OPINION ON DRUG DISCOVERY. 12 p.Research output: Contribution to journal › Review article › peer-review
-
ADP-heptose attenuates Helicobacter pylori-induced dendritic cell activation
Neuper, T., Frauenlob, T., Dang, H.-H., Krenn, P. W. (Co-author), Posselt, G., Regl, C., Fortelny, N., Schaepertoens, V., Unger, M. S. (Co-author), Ueblagger, G., Neureiter, D. (Co-author), Muehlbacher, I. (Co-author), Weitzendorfer, M. (Co-author), Singhartinger, F. (Co-author), Emmanuel, K. (Co-author), Huber, C. G., Wessler, S., Aberger, F. & Horejs-Hoeck, J., 31 Dec 2024, In: Gut Microbes. 16, 1, 24 p., 2402543.Research output: Contribution to journal › Original Article › peer-review
Open Access2 Citations (Web of Science) -
Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials
Kiem, D. (First author), Ocker, M., Greil, R. (Co-author), Neureiter, D. (Co-author) & Melchardt, T. (Last author), Mar 2024, In: EXPERT OPINION ON INVESTIGATIONAL DRUGS. 33, 3, p. 229-242 14 p.Research output: Contribution to journal › Review article › peer-review
Projects
- 1 Finished
-
Evaluating the impact of XPO1 mRNA expression on the molecular landscape and on selinexor response in pancreatic ductal adenocarcinoma
Neureiter, D. (PI)
20/12/22 → 20/12/24
Project: Research
Prizes
-
Bearbeitung von wissenschaftlichen Fragestellungen im Bereich von unterschiedlichen hämato-onkologischen Tumorentitäten
Neureiter, D. (Cooperation)
2013Activity: Other scientific activities › Cooperation
-
SpringerWienNewYork (Publisher)
Greil, R. (Editor in chief), Pleyer, L. (Editor in chief), Neureiter, D. (Editor in chief) & Faber, V. (Editor in chief)
2010Activity: Publication peer-review and editorial work › Editorial work
-
Bearbeitung von wissenschaftlichen Fragestellungen im Bereich von unterschiedlichen gastrointestinalen Tumorentitäten
Neureiter, D. (Cooperation)
2005Activity: Other scientific activities › Cooperation
-
Bearbeitung von wissenschaftlichen Fragestellungen im Bereich von unterschiedlichen hämato-onkologoschen Tumorentitäten
Neureiter, D. (Cooperation)
2005Activity: Other scientific activities › Cooperation